Cardiovascular Disorder TRIZ Cases
- Cardiac Valve Therapy Using Targeted RNA-Seq Drug Screening
Targeted RNA-seq screening identifies compounds that restore dysregulated valve gene expression, reduce calcification, and may delay CAVD progression.
- α7nAChR Agonist Composition for Ischemia-Reperfusion Inflammation
Varenicline activates α7nAChR to suppress reperfusion-driven inflammation, oxidative stress, and fibrosis while preserving organ function.
- miR-92 Antagonists for HFpEF Diastolic Dysfunction
Nucleic acid miR-92 antagonists target reduced ventricular elasticity and diastolic dysfunction to improve outcomes in HFpEF.